Sihuan Pharmaceutical Holdings Group Ltd. logo

Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

Market Closed
25 Jul, 20:00
OTC PINK OTC PINK
$
0. 10
0
0%
$
1.13B Market Cap
- P/E Ratio
0.04% Div Yield
0 Volume
- Eps
$ 0.1
Previous Close
Day Range
0.1 0.1
Year Range
0.05 0.12
Want to track SHPHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 32 days

Summary

SHPHF closed Friday higher at $0.1, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, SHPHF stock gained 103.25%.
SHPHF pays dividends to its shareholders, with the most recent payment made on Oct 10, 2024. The next estimated payment will be in 9 months ago on Oct 10, 2024 for a total of $0.0027.
The last earnings report, released on Mar 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 29, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

SHPHF Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Sihuan Pharmaceutical Holdings Group Ltd. Dividends

Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 9 months ago
Paid
Other
$0 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 10 months ago
Other
$0 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 7 Jun 2023
Paid
Other
$0.04 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 6 Jun 2023
Other
$0.01 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 4 Oct 2022
Paid
Other
$0.04 Per Share

Sihuan Pharmaceutical Holdings Group Ltd. Earnings

29 Aug 2025 (In 1 month) Date
-
Cons. EPS
-
EPS
26 Mar 2025 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS
27 Aug 2024 Date
-
Cons. EPS
-
EPS
6 Jun 2024 Date
-
Cons. EPS
-
EPS
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 9 months ago
Paid
Other
$0 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 10 months ago
Other
$0 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 7 Jun 2023
Paid
Other
$0.04 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 6 Jun 2023
Other
$0.01 Per Share
Sihuan Pharmaceutical Holdings Group Ltd. logo
SHPHF 4 Oct 2022
Paid
Other
$0.04 Per Share
29 Aug 2025 (In 1 month) Date
-
Cons. EPS
-
EPS
26 Mar 2025 Date
-
Cons. EPS
-
EPS
30 Aug 2024 Date
-
Cons. EPS
-
EPS
27 Aug 2024 Date
-
Cons. EPS
-
EPS
6 Jun 2024 Date
-
Cons. EPS
-
EPS

Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF) FAQ

What is the stock price today?

The current price is $0.10.

On which exchange is it traded?

Sihuan Pharmaceutical Holdings Group Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is SHPHF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.04%.

What is its market cap?

As of today, the market cap is 1.13B.

When is the next earnings date?

The next earnings report will release on Aug 29, 2025.

Has Sihuan Pharmaceutical Holdings Group Ltd. ever had a stock split?

No, there has never been a stock split.

Sihuan Pharmaceutical Holdings Group Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Dr. Weicheng Guo Ph.D. CEO
OTC PINK Exchange
BMG8162K1137 ISIN
Hong Kong Country
2,667 Employees
2 Oct 2024 Last Dividend
5 Jun 2014 Last Split
- IPO Date

Overview

Sihuan Pharmaceutical Holdings Group Ltd., established in 2001 and headquartered in Wan Chai, Hong Kong, operates as a robust player in the pharmaceutical sector within the People's Republic of China. As an investment holding entity, the company’s primary activities encompass the research and development, manufacture, marketing, and sales of a diverse range of pharmaceutical and medical aesthetic products. It boasts a broad product portfolio that includes therapeutic solutions in critical areas such as oncology, metabolism, diabetes, cardiovascular and cerebrovascular diseases, modern Chinese medicine, and industrial hemp treatments. Additionally, Sihuan Pharmaceutical extends its market presence to the investment and sale of medical beauty products, the manufacturing of medical instruments, property investments, the construction of medical projects, and project preparation for pharmaceutical products manufacturing. The company is also engaged in providing a variety of services including information support, general and hospital management, biotechnology, technology promotion, and medical aesthetic research and development, making it a comprehensive provider in the healthcare and pharmaceutical industries in China.

Products and Services

  • Oncology Drugs

    Sihuan Pharmaceutical offers a wide range of oncology drugs designed to treat various types of cancer by inhibiting the growth of cancer cells, thereby providing patients with vital treatment options to manage their conditions.

  • Metabolism and Diabetes Treatments

    The company provides medications that target the metabolism and diabetes sector, focusing on improving the lives of people living with metabolic disorders and diabetes through innovative therapeutic solutions.

  • Cardiovascular and Cerebrovascular Medications

    Sihuan Pharmaceutical develops drugs aimed at treating cardiovascular and cerebrovascular diseases, contributing to the prevention and management of heart conditions and strokes through cutting-edge pharmacological treatment.

  • Modern Chinese Medicine

    Embracing the rich heritage of traditional Chinese medical practices, the company also specializes in the production and marketing of modern Chinese medicine formulations, offering alternatives to conventional medicine and enhancing patient care with holistic approaches.

  • Industrial Hemp Therapeutic Solutions

    Exploring the therapeutic potential of industrial hemp, Sihuan Pharmaceutical is at the forefront of developing and supplying products derived from industrial hemp, targeting a variety of medical conditions with natural solutions.

  • Medical Beauty Products

    The company's foray into medical aesthetics involves the investment and sale of medical beauty products, leveraging biotechnology to offer innovative cosmetic solutions that meet diverse beauty and skincare needs.

  • Medical Instruments Manufacturing

    Complementing its pharmaceutical and medical beauty product lines, Sihuan Pharmaceutical also engages in the manufacture of medical instruments, ensuring the availability of high-quality tools and devices for healthcare providers.

  • Property Investments and Construction for Medical Projects

    Extending its expertise beyond pharmaceuticals, the company invests in properties and undertakes the construction of medical projects, demonstrating its multifaceted approach to supporting healthcare infrastructure.

  • Information Support and Hospital Management Services

    With services that span information support and hospital management, Sihuan Pharmaceutical offers comprehensive solutions to improve hospital operations and patient care through technology and effective management practices.

  • Biotechnology, Technology Promotion, and R&D in Medical Aesthetics

    The company is devoted to the promotion of biotechnology and the advancement of medical aesthetic research and development, showcasing its commitment to innovation and the future of medical care.

Contact Information

Address: Office Tower, Convention Plaza
Phone: 852 3628 3911